| UniProt ID | RL26_HUMAN | |
|---|---|---|
| UniProt AC | P61254 | |
| Protein Name | 60S ribosomal protein L26 | |
| Gene Name | RPL26 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 145 | |
| Subcellular Localization | ||
| Protein Description | Component of the large ribosomal subunit.. | |
| Protein Sequence | MKFNPFVTSDRSKNRKRHFNAPSHIRRKIMSSPLSKELRQKYNVRSMPIRKDDEVQVVRGHYKGQQIGKVVQVYRKKYVIYIERVQREKANGTTVHVGIHPSKVVITRLKLDKDRKKILERKAKSRQVGKEKGKYKEETIEKMQE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Sulfoxidation | -------MKFNPFVT -------CCCCCCCC | 11.45 | 28183972 | |
| 2 | Acetylation | ------MKFNPFVTS ------CCCCCCCCC | 54.57 | 133641 | |
| 2 | Methylation | ------MKFNPFVTS ------CCCCCCCCC | 54.57 | 133641 | |
| 2 | Sumoylation | ------MKFNPFVTS ------CCCCCCCCC | 54.57 | - | |
| 2 | Sumoylation | ------MKFNPFVTS ------CCCCCCCCC | 54.57 | - | |
| 2 | Ubiquitination | ------MKFNPFVTS ------CCCCCCCCC | 54.57 | 23000965 | |
| 8 | Phosphorylation | MKFNPFVTSDRSKNR CCCCCCCCCCCCCCC | 25.86 | 21815630 | |
| 9 | Phosphorylation | KFNPFVTSDRSKNRK CCCCCCCCCCCCCCC | 26.23 | 21815630 | |
| 11 | Methylation | NPFVTSDRSKNRKRH CCCCCCCCCCCCCCC | 49.66 | - | |
| 12 | Phosphorylation | PFVTSDRSKNRKRHF CCCCCCCCCCCCCCC | 38.99 | 25159151 | |
| 13 | Acetylation | FVTSDRSKNRKRHFN CCCCCCCCCCCCCCC | 62.76 | 20167786 | |
| 16 | Acetylation | SDRSKNRKRHFNAPS CCCCCCCCCCCCCCH | 60.67 | 7935065 | |
| 17 | Methylation | DRSKNRKRHFNAPSH CCCCCCCCCCCCCHH | 36.07 | 115491925 | |
| 23 | Phosphorylation | KRHFNAPSHIRRKIM CCCCCCCHHHHHHHH | 29.18 | 29214152 | |
| 26 | Methylation | FNAPSHIRRKIMSSP CCCCHHHHHHHHCCC | 28.54 | 115491917 | |
| 28 | Ubiquitination | APSHIRRKIMSSPLS CCHHHHHHHHCCCCC | 32.67 | 33845483 | |
| 30 | Sulfoxidation | SHIRRKIMSSPLSKE HHHHHHHHCCCCCHH | 3.49 | 30846556 | |
| 31 | Phosphorylation | HIRRKIMSSPLSKEL HHHHHHHCCCCCHHH | 32.07 | 23911959 | |
| 32 | Phosphorylation | IRRKIMSSPLSKELR HHHHHHCCCCCHHHH | 16.69 | 25159151 | |
| 35 | Phosphorylation | KIMSSPLSKELRQKY HHHCCCCCHHHHHHH | 27.71 | 30206219 | |
| 36 | Acetylation | IMSSPLSKELRQKYN HHCCCCCHHHHHHHC | 69.33 | 26051181 | |
| 36 | 2-Hydroxyisobutyrylation | IMSSPLSKELRQKYN HHCCCCCHHHHHHHC | 69.33 | - | |
| 36 | Ubiquitination | IMSSPLSKELRQKYN HHCCCCCHHHHHHHC | 69.33 | 23000965 | |
| 41 | Ubiquitination | LSKELRQKYNVRSMP CCHHHHHHHCCCCCC | 32.15 | 23000965 | |
| 46 | Phosphorylation | RQKYNVRSMPIRKDD HHHHCCCCCCCCCCC | 25.32 | 29214152 | |
| 51 | Acetylation | VRSMPIRKDDEVQVV CCCCCCCCCCCEEEE | 70.96 | 23236377 | |
| 51 | Ubiquitination | VRSMPIRKDDEVQVV CCCCCCCCCCCEEEE | 70.96 | 21906983 | |
| 59 | Methylation | DDEVQVVRGHYKGQQ CCCEEEEECEECCCC | 27.58 | - | |
| 63 | Ubiquitination | QVVRGHYKGQQIGKV EEEECEECCCCCCCE | 44.56 | 23000965 | |
| 63 | Acetylation | QVVRGHYKGQQIGKV EEEECEECCCCCCCE | 44.56 | 26051181 | |
| 63 | Succinylation | QVVRGHYKGQQIGKV EEEECEECCCCCCCE | 44.56 | 23954790 | |
| 69 | Acetylation | YKGQQIGKVVQVYRK ECCCCCCCEEEEEEE | 40.64 | 23236377 | |
| 69 | 2-Hydroxyisobutyrylation | YKGQQIGKVVQVYRK ECCCCCCCEEEEEEE | 40.64 | - | |
| 69 | Malonylation | YKGQQIGKVVQVYRK ECCCCCCCEEEEEEE | 40.64 | 26320211 | |
| 69 | Ubiquitination | YKGQQIGKVVQVYRK ECCCCCCCEEEEEEE | 40.64 | 23000965 | |
| 76 | Ubiquitination | KVVQVYRKKYVIYIE CEEEEEEECEEEEEE | 30.67 | - | |
| 76 | Acetylation | KVVQVYRKKYVIYIE CEEEEEEECEEEEEE | 30.67 | 25953088 | |
| 77 | Acetylation | VVQVYRKKYVIYIER EEEEEEECEEEEEEE | 35.43 | 25825284 | |
| 77 | 2-Hydroxyisobutyrylation | VVQVYRKKYVIYIER EEEEEEECEEEEEEE | 35.43 | - | |
| 77 | Ubiquitination | VVQVYRKKYVIYIER EEEEEEECEEEEEEE | 35.43 | 33845483 | |
| 84 | Methylation | KYVIYIERVQREKAN CEEEEEEEEHHHHCC | 21.95 | - | |
| 89 | Acetylation | IERVQREKANGTTVH EEEEHHHHCCCCEEE | 49.71 | 26051181 | |
| 89 | Ubiquitination | IERVQREKANGTTVH EEEEHHHHCCCCEEE | 49.71 | 33845483 | |
| 103 | Acetylation | HVGIHPSKVVITRLK EEEECHHHEEEEEEE | 45.00 | 26051181 | |
| 103 | Ubiquitination | HVGIHPSKVVITRLK EEEECHHHEEEEEEE | 45.00 | 23000965 | |
| 103 | Methylation | HVGIHPSKVVITRLK EEEECHHHEEEEEEE | 45.00 | - | |
| 110 | Acetylation | KVVITRLKLDKDRKK HEEEEEEECCHHHHH | 51.88 | 25953088 | |
| 113 | Ubiquitination | ITRLKLDKDRKKILE EEEEECCHHHHHHHH | 70.62 | - | |
| 113 | Acetylation | ITRLKLDKDRKKILE EEEEECCHHHHHHHH | 70.62 | 26051181 | |
| 134 | Ubiquitination | QVGKEKGKYKEETIE HHHHHHCCCCHHHHH | 65.30 | 29967540 | |
| 134 | Acetylation | QVGKEKGKYKEETIE HHHHHHCCCCHHHHH | 65.30 | 23749302 | |
| 135 | Phosphorylation | VGKEKGKYKEETIEK HHHHHCCCCHHHHHH | 32.09 | 28152594 | |
| 136 | Sumoylation | GKEKGKYKEETIEKM HHHHCCCCHHHHHHH | 53.19 | 28112733 | |
| 136 | Ubiquitination | GKEKGKYKEETIEKM HHHHCCCCHHHHHHH | 53.19 | 24816145 | |
| 136 | Sumoylation | GKEKGKYKEETIEKM HHHHCCCCHHHHHHH | 53.19 | - | |
| 136 | Acetylation | GKEKGKYKEETIEKM HHHHCCCCHHHHHHH | 53.19 | 26051181 | |
| 139 | Phosphorylation | KGKYKEETIEKMQE- HCCCCHHHHHHHHC- | 35.21 | 25159151 | |
| 142 | 2-Hydroxyisobutyrylation | YKEETIEKMQE---- CCHHHHHHHHC---- | 41.87 | - | |
| 142 | Ubiquitination | YKEETIEKMQE---- CCHHHHHHHHC---- | 41.87 | 21906983 | |
| 142 | Acetylation | YKEETIEKMQE---- CCHHHHHHHHC---- | 41.87 | 25953088 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL26_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL26_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614900 | Diamond-Blackfan anemia 11 (DBA11) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-77, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-139, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-139, AND MASSSPECTROMETRY. | |